2021年浙江省肿瘤登记地区肾癌发病与死亡特征及2000-2021年变化趋势分析
Kidney Cancer Incidence and Mortality in Zhejiang Cancer Registration Areas in 2021 and Trends from 2000 to 2021
投稿时间:2025-06-27  修订日期:2025-09-18
DOI:
中文关键词:  肾癌  发病率  死亡率  变化趋势  浙江
英文关键词:Kidney cancer  incidence  mortality  change trends  Zhejiang
基金项目:
作者单位邮编
胥雪红 宁波市奉化区疾病预防控制中心 315500
杜飞行 宁波市奉化区疾病预防控制中心 315500
李益 宁波市奉化区疾病预防控制中心 315500
周福军 宁波市奉化区疾病预防控制中心 315500
冯伟 宁波市奉化区疾病预防控制中心 315500
李辉章 浙江省肿瘤医院 310022
杜灵彬* 浙江省肿瘤医院 310022
摘要点击次数: 105
全文下载次数: 0
中文摘要:
      目的 分析2021年浙江省肿瘤登记地区肾癌的发病与死亡特征及2000-2021年变化趋势。方法 整理浙江省22个肿瘤登记处2000-2021年肾癌数据资料,计算粗发病/死亡率、中标发病/死亡率、世标发病/死亡率、累积率及截缩率等指标描述现状,采用Join point 回归模型计算中标率的平均年度变化百分比(average annual percentage change, AAPC)分析流行趋势。结果 2021年浙江省肾癌中标发病率为5.51/10万,其中男性为7.35/10万,女性为3.73/10万,城市为5.99/10万,农村为4.76/10万。0-74岁累积发病率为0.62%,35-64岁截缩发病率为9.75/10万。肾癌中标死亡率为1.01/10万,其中男性为1.38/10万,女性为0.66/10万,城市为1.01/10万,农村为1.02/10万。0-74岁累积死亡率为0.09%,35-64岁截缩死亡率为1.02/10万。发病率和死亡率均呈现男性高于女性,城市高于农村。发病率在25岁后随年龄持续快速增长,男性和城市增长速率快于女性和农村,并均在65岁后增长速度开始放缓,70-79岁达峰值。死亡率在50岁后随年龄持续快速增长,男性和城市增长速率快于女性和农村,除农村女性外,增长速度未见明显放缓,在85岁以上年龄组达到峰值。2000-2021年肾癌发病率呈逐年上升趋势(APC=2.79%,95%CI: 1.76% ~ 3.87%,P<0.05),农村男性增长最快(AAPC=13.63 %,95%CI: 9.52% ~ 16.78%,P<0.05)。2000-2021年肾癌死亡率呈逐年上升趋势(APC=2.44%,95%CI: 1.18% ~ 3.73%,P<0.05),农村女性增长最快(AAPC=52.79%,95%CI: 26.58% ~ 71.42%,P<0.05)。结论 浙江省肿瘤登记地区肾癌发病水平较高,发病和死亡率呈现逐年上升趋势需引起重视,城市男性为重点防控对象。
英文摘要:
      [Purpose] To analyze kidney cancer incidence and mortality in Zhejiang cancer registration areas in 2021 and the trends from 2000 to 2021. [Methods] The data of kidney cancer reported by the Zhejiang provincial cancer registries from 2000 to 2021 were collected. The crude incidence and mortality rates were calculated, along with age-standardized rates using the Chinese standard population (ASIRC and ASMRC) and the world standard population (ASIRW and ASMRW), as well as the cumulative rate (0~74 years) and the truncated rate (35~64 years), to characterize the current situation. The average annual percentage change (AAPC) was derived using the Join point regression model to the epidemiological analyze trend. [Results] In 2021, the ASIRC in Zhejiang Province was 5.51/105, of which 7.35/105 for males, 3.73/105 for females, 5.99/105 in urban areas and 4.76/105 in rural areas. The cumulative incidence rate(0~74 years) was 0.62%, and the truncated incidence rate(35~64 years) was 9.75/105. The ASMRC was 1.01/105, of which 1.38/105 for men, 0.66/105 for females, 1.01/105 in urban areas and 1.02/105 in rural areas. The cumulative mortality rate(0~74 years) was 0.09% and the truncated mortality rate (35~64 years) was 1.02/105. Incidence and mortality rates were higher for males than for females, and higher in urban than in rural areas. Incidence rates continued to increase rapidly with age after 25 years, with males and urban areas increasing faster than females and rural areas, and the growth rate began to slow down after 65 years, reaching a peak at 70-79 years. The mortality rate continued to increase rapidly with age after 50 years, with males and urban areas increasing at a faster rate than females and rural areas, except for rural females, where the rate of increase did not slow down significantly, peaking in the age group of 85 years or older. The incidence rate of kidney cancer showed an increasing trend year by year from 2000 to 2021 (AAPC=2.79 %, 95%CI: 1.76% ~ 3.87%, P<0.05), with the fastest increase in the rural males (AAPC=13.63 %, 95%CI: 9.52% ~ 16.78%, P<0.05). The mortality rate of kidney cancer showed an increasing trend year by year from 2000 to 2021 (AAPC=2.44%, 95%CI: 1.18% ~ 3.73%, P<0.05), with the fastest increase in rural females (AAPC=52.79%, 95%CI: 26.58% ~ 71.42%, P<0.05). [Conclusion] The incidence of kidney cancer in Zhejiang cancer registration areas was relatively high, with both incidence and mortality rates showing an upward trend that warrants attention. Urban males constitute the primary target group for prevention and control efforts.
在线阅读     查看/发表评论  下载PDF阅读器